SubjectWell Appoints Veteran Healthcare Finance Leader Karl Stubelis as Chief Financial Officer

AUSTIN, Texas, July 24, 2025 /PRNewswire/ — SubjectWell, the Patient Experience Platform driving predictable clinical trial enrollment and patient retention, has announced the appointment of Karl Stubelis as its new Chief Financial Officer. A seasoned executive with more than 25 years of leadership across high-growth healthcare, life sciences, and technology companies, Stubelis will oversee SubjectWell’s financial strategy as the company continues to scale its platform and expand its global reach. 

Stubelis brings a deep track record of success across venture-backed startups, private equity portfolio companies, and publicly traded firms. Most recently, he served as CFO at Verb Biotics, where he led financial strategy in the emerging probiotics sector. Prior to that, he held senior roles at Exact Sciences and Thrive Earlier Detection, playing a pivotal role in Thrive’s multi-billion-dollar acquisition by Exact. Stubelis has also served as CFO at several SaaS healthcare companies including Athenahealth, Ovia Health, and Arcadia. 

At Athenahealth, Stubelis served as both CFO and SVP during a transformative period, managing global financial operations while navigating public markets, activist investors, and regulatory shifts. Earlier in his career, he held international finance leadership roles at Sapient, overseeing teams and integrations across 15+ countries. 

“As SubjectWell enters a new chapter of growth, Karl’s experience at the intersection of healthcare and technology positions him to play a critical role in our continued evolution,” said Fred Martin, CEO of SubjectWell. “His proven track record in scaling operations, executing strategic transactions, and guiding companies through pivotal transitions will be instrumental as we broaden our global reach and deepen our impact on the clinical trial ecosystem—benefiting patients, customers, and communities worldwide.” 

Stubelis holds a B.S. in Finance from the University of Vermont and an MBA from Suffolk University. 

About SubjectWell
As the premier Patient Experience Platform, SubjectWell drives predictable trial enrollment and improves retention by enhancing the patient journey from protocol design through study completion. Powered by technology, global reach, full-service creative and a suite of services to reduce site burden—SubjectWell drives intelligence and efficiency for sponsors, CROs, sites, and site networks. From protocol development through recruitment, enrollment, retention, and post-trial real-world evidence studies, SubjectWell supports the entire clinical lifecycle. 

Media Contact:
Interdependence Public Relations
Alysha Swisher/Haylee Elmore
602-350-1455
398546@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/subjectwell-appoints-veteran-healthcare-finance-leader-karl-stubelis-as-chief-financial-officer-302512518.html

SOURCE SubjectWell

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

20 minutes ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

5 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

6 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

6 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

6 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

11 hours ago